Home page > Pipeline > Fabry Disease
as.png am.png am.png
print.png
email.png

Authorize the processing of personal data
Edit email address
Invalid email
Email Sent
Authorize the processing of personal data

Fabry Disease

Fabry disease is a lysosomal storage disorder, meaning that a glycosphingolipid called GL-3 accumulates in the lysosomes, causing tissue damage; many cell types are affected.1

The disease is caused by mutations in the GLA gene, resulting in nonfunctional or dysfunctional alpha-galactosidase A, a lysosomal enzyme. The mutations can be inherited, so multiple family members can have the disease.1

Fabry disease is a multisystemic disease, affecting many organs, including the heart, kidney and nervous system, resulting in life-threatening complications and a reduced life expectancy. Early signs of the disease start in childhood and adolescence, but it is a progressive, lifelong condition.1,2
Newborn screening has now been performed in several countries, yielding a prevalence ranging from 1 in 1,368 to 1 in 8,882 births.2

  1. Wanner C, et al. Mol Genet Metab 2018;124(3):189-203.
  2. Cairns T, et al. Postgrad Med J 2018;94(1118):709-713.